LEUVEN, Belgium, May 13, 2016 /PRNewswire/ --
Developing Novel Medicines Targeting Diabetic Eye Disease
Highlights
ThromboGenics is focused on developing novel medicines for the treatment of diabetic eye disease
ThromboGenics presented its new drug development...